{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anti-viral", "CBA", "Glycan", "HIV-1", "Lectin", "MoMo30-plant", "Momordica", "gp120"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36949470", "DateCompleted": {"Year": "2023", "Month": "03", "Day": "24"}, "DateRevised": {"Year": "2023", "Month": "05", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "03", "Day": "22"}], "Language": ["eng"], "ELocationID": ["50", "10.1186/s12985-023-02010-5"], "Journal": {"ISSN": "1743-422X", "JournalIssue": {"Volume": "20", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Mar", "Day": "22"}}, "Title": "Virology journal", "ISOAbbreviation": "Virol J"}, "ArticleTitle": "Anti-human immunodeficiency virus-1 activity of MoMo30 protein isolated from the traditional African medicinal plant Momordica balsamina.", "Pagination": {"StartPage": "50", "MedlinePgn": "50"}, "Abstract": {"AbstractText": ["Plants are used in traditional healing practices of many cultures worldwide. Momordica balsamina is a plant commonly used by traditional African healers as a part of a treatment for HIV/AIDS. It is typically given as a tea to patients with HIV/AIDS. Water-soluble extracts of this plant were found to contain anti-HIV activity.", "We employed cell-based infectivity assays, surface plasmon resonance, and a molecular-cell model of the gp120-CD4 interaction to study the mechanism of action of the MoMo30-plant protein. Using Edman degradation results of the 15 N-terminal amino acids, we determined the gene sequence of the MoMo30-plant protein from an RNAseq library from total RNA extracted from Momordica balsamina.", "Here, we identify the active ingredient of water extracts of the leaves of Momordica balsamina as a 30\u00a0kDa protein we call MoMo30-plant. We have identified the gene for MoMo30 and found it is homologous to a group of plant lectins known as Hevamine A-like proteins. MoMo30-plant is distinct from other proteins previously reported agents from the Momordica species, such as ribosome-inactivating proteins such as MAP30 and Balsamin. MoMo30-plant binds to gp120 through its glycan groups and functions as a lectin or carbohydrate-binding agent (CBA). It inhibits HIV-1 at nanomolar levels and has minimal cellular toxicity at inhibitory levels.", "CBAs like MoMo30 can bind to glycans on the surface of the enveloped glycoprotein of HIV (gp120) and block entry. Exposure to CBAs has two effects on the virus. First, it blocks infection of susceptible cells. Secondly, MoMo30 drives the selection of viruses with altered glycosylation patterns, potentially altering their immunogenicity. Such an agent could represent a change in the treatment strategy for HIV/AIDS that allows a rapid reduction in viral loads while selecting for an underglycosylated virus, potentially facilitating the host immune response."], "CopyrightInformation": "\u00a9 2023. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA, 30310, USA."}], "LastName": "Khan", "ForeName": "Mahfuz", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Malango Traditional Healers Association, Fatick, Senegal."}], "LastName": "Diop", "ForeName": "Amad", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "PROMETRA International, BP 6134, Dakar-Etoile, Senegal."}], "LastName": "Gbodossou", "ForeName": "Erick", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology Director, New Iberia Research Center, University of Louisiana at Lafayette, 4401 W Admiral Doyle Drive, New Iberia, LA, 70560, USA."}], "LastName": "Xiao", "ForeName": "Peng", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA, 30310, USA."}], "LastName": "Coleman", "ForeName": "Morgan", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA, 30310, USA."}], "LastName": "De Barros", "ForeName": "Kenya", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA, 30310, USA."}], "LastName": "Duong", "ForeName": "Hao", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA, 30310, USA."}], "LastName": "Bond", "ForeName": "Vincent C", "Initials": "VC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Community Health and Preventive Medicine, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA, 30310, USA."}], "LastName": "Floyd", "ForeName": "Virginia", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Community Health and Preventive Medicine, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA, 30310, USA."}], "LastName": "Kondwani", "ForeName": "Kofi", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Office of the President, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA, 30310, USA."}], "LastName": "Rice", "ForeName": "Valerie Montgomery", "Initials": "VM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology Senior Vice President for External Affairs and Innovation, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA, 30310, USA."}], "LastName": "Harris-Hooker", "ForeName": "Sandra", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology Director, New Iberia Research Center, University of Louisiana at Lafayette, 4401 W Admiral Doyle Drive, New Iberia, LA, 70560, USA."}], "LastName": "Villinger", "ForeName": "Francois", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA, 30310, USA. mpowell@msm.edu."}], "LastName": "Powell", "ForeName": "Michael D", "Initials": "MD"}], "GrantList": [{"GrantID": "R16 GM146703", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}, {"GrantID": "R24 OD010947", "Acronym": "OD", "Agency": "NIH HHS", "Country": "United States"}, {"GrantID": "U54 MD007602", "Acronym": "MD", "Agency": "NIMHD NIH HHS", "Country": "United States"}, {"GrantID": "1 R16 GM146703A-01", "Acronym": "NH", "Agency": "NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Virol J", "NlmUniqueID": "101231645", "ISSNLinking": "1743-422X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "HIV Envelope Protein gp120"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics"], "DescriptorName": "HIV-1"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Acquired Immunodeficiency Syndrome"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Momordica"}, {"QualifierName": ["metabolism"], "DescriptorName": "Plant Proteins"}, {"QualifierName": ["genetics", "metabolism", "pharmacology"], "DescriptorName": "HIV Envelope Protein gp120"}], "CoiStatement": "The authors report no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Davids D, Blouws T, Aboyade O, Gibson D, De Jong JT, Van't Klooster C, Hughes G. Traditional health practitioners' perceptions, herbal treatment and management of HIV and related opportunistic infections. J Ethnobiol Ethnomed. 2014;10:77. doi: 10.1186/1746-4269-10-77.", "ArticleIdList": ["10.1186/1746-4269-10-77", "PMC4414384", "25480758"]}, {"Citation": "van Wyk BE, Albrecht C. A review of the taxonomy, ethnobotany, chemistry and pharmacology of Sutherlandia frutescens (Fabaceae) J Ethnopharmacol. 2008;119:620\u2013629. doi: 10.1016/j.jep.2008.08.003.", "ArticleIdList": ["10.1016/j.jep.2008.08.003", "18761068"]}, {"Citation": "Fridlender M, Kapulnik Y, Koltai H. Plant derived substances with anti-cancer activity: from folklore to practice. Front Plant Sci. 2015;6:799. doi: 10.3389/fpls.2015.00799.", "ArticleIdList": ["10.3389/fpls.2015.00799", "PMC4589652", "26483815"]}, {"Citation": "Thomford NE, Dzobo K, Chopera D, Wonkam A, Skelton M, Blackhurst D, Chirikure S, Dandara C. Pharmacogenomics implications of using herbal medicinal plants on African populations in health transition. Pharmaceuticals (Basel) 2015;8:637\u2013663. doi: 10.3390/ph8030637.", "ArticleIdList": ["10.3390/ph8030637", "PMC4588186", "26402689"]}, {"Citation": "Mukhtar M, Arshad M, Ahmad M, Pomerantz RJ, Wigdahl B, Parveen Z. Antiviral potentials of medicinal plants. Virus Res. 2008;131:111\u2013120. doi: 10.1016/j.virusres.2007.09.008.", "ArticleIdList": ["10.1016/j.virusres.2007.09.008", "PMC7114233", "17981353"]}, {"Citation": "Jeffrey C. A review of the Cucurbitaceae. Bot J Linn Soc. 2008;81:233\u2013247. doi: 10.1111/j.1095-8339.1980.tb01676.x.", "ArticleIdList": ["10.1111/j.1095-8339.1980.tb01676.x"]}, {"Citation": "Saboo S, Thorat PK, Tapadiya G, Khadabadi SS. Ancient and recent medicinal uses of cucurbitaceae family. Int J Ther Appl. 2013;9:11\u201319."}, {"Citation": "Bortolotti M, Mercatelli D, Polito L. Momordica charantia, a nutraceutical approach for inflammatory related diseases. Front Pharmacol. 2019;10:486. doi: 10.3389/fphar.2019.00486.", "ArticleIdList": ["10.3389/fphar.2019.00486", "PMC6517695", "31139079"]}, {"Citation": "Karunanayake EH, Jeevathayaparan S, Tennekooon KH. Effect of Momordica charantia fruit juice on streptozotocin-induced diabetes in rats. J Ethnopharmacol. 1990;30:199\u2013204. doi: 10.1016/0378-8741(90)90008-H.", "ArticleIdList": ["10.1016/0378-8741(90)90008-H", "2255210"]}, {"Citation": "Ahmed I, Cummings E, Adeghate E, Sharma AK, Singh J. Beneficial effects and mechanism of action of Momordica charantia fruit juice in the treatment of streptozotocin-induced diabetes mellitus in rats. Mol Cell Biochem. 2004;261:63\u201370. doi: 10.1023/B:MCBI.0000028738.95518.90.", "ArticleIdList": ["10.1023/B:MCBI.0000028738.95518.90", "15362486"]}, {"Citation": "Garau C, Adeghate I, Cummings E, Singh J. Beneficial effects and mechanism of action of Momordica charantia in the treatment of diabetes mellitus. Int J Diabetes Metab. 2003;11:46\u201355."}, {"Citation": "Licastro F, Franceschi C, Barbieri L, Stirpe F. Toxicity of Momordica charantia lectin and inhibitor for human normal and leukaemic lymphocytes. Virchows Archiv B. 1980;33:257\u2013265. doi: 10.1007/BF02899186.", "ArticleIdList": ["10.1007/BF02899186", "6110273"]}, {"Citation": "Chan WY, Ng TB, Yeung HW. beta-Momorcharin, a plant glycoprotein, inhibits synthesis of macromolecules in embryos, splenocytes and tumor cells. Int J Biochem. 1992;24:1039\u20131046. doi: 10.1016/0020-711X(92)90371-7.", "ArticleIdList": ["10.1016/0020-711X(92)90371-7", "1383043"]}, {"Citation": "Grover JK, Yadav SP. Pharmacological actions and potential uses of Momordica charantia; a review. J Ethanopharmacol. 2004;93:123\u2013132. doi: 10.1016/j.jep.2004.03.035.", "ArticleIdList": ["10.1016/j.jep.2004.03.035", "15182917"]}, {"Citation": "Lee-Huang S, Huang PL, Chen HC, Huang PL, Bourinbaiar A, Huang HI, Kung HF. Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon. Gene. 1995;161:151\u2013156. doi: 10.1016/0378-1119(95)00186-A.", "ArticleIdList": ["10.1016/0378-1119(95)00186-A", "7665070"]}, {"Citation": "Lee-Huang S, Huang PL, Huang PL, Bourinbaiar AS, Chen HC, Kung HF. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. Proc Natl Acad Sci USA. 1995;92:8818\u20138822. doi: 10.1073/pnas.92.19.8818.", "ArticleIdList": ["10.1073/pnas.92.19.8818", "PMC41058", "7568024"]}, {"Citation": "Zhu F, Zhou YK, Ji ZL, Chen XR. The plant ribosome-inactivating proteins play important roles in defense against pathogens and insect pest attacks. Front Plant Sci. 2018;9:146. doi: 10.3389/fpls.2018.00146.", "ArticleIdList": ["10.3389/fpls.2018.00146", "PMC5811460", "29479367"]}, {"Citation": "Fan JM, Zhang Q, Xu J, Zhu S, Ke T, Gao DF, Xu YB. Inhibition on Hepatitis B virus in vitro of recombinant MAP30 from bitter melon. Mol Biol Rep. 2009;36:381\u2013388. doi: 10.1007/s11033-007-9191-2.", "ArticleIdList": ["10.1007/s11033-007-9191-2", "18058255"]}, {"Citation": "Ajji PK, Sonkar SP, Walder K, Puri M. Purification and functional characterization of recombinant balsamin, a ribosome-inactivating protein from Momordica balsamina. Int J Biol Macromol. 2018;114:226\u2013234. doi: 10.1016/j.ijbiomac.2018.02.114.", "ArticleIdList": ["10.1016/j.ijbiomac.2018.02.114", "29471092"]}, {"Citation": "Kaur I, Puri M, Ahmed Z, Blanchet FP, Mangeat B, Piguet V. Inhibition of HIV-1 replication by balsamin, a ribosome inactivating protein of Momordica balsamina. PLoS ONE. 2013;8:e73780. doi: 10.1371/journal.pone.0073780.", "ArticleIdList": ["10.1371/journal.pone.0073780", "PMC3764001", "24040067"]}, {"Citation": "Mshelia HS, Karumi Y, Dibal NI. Therapeutic effect of Momordica balsamina leaf extract on ethanol-induced gastric ulcer in Wistar rats. Ann Res Hosp. 2017;1:3. doi: 10.21037/arh.2017.04.03.", "ArticleIdList": ["10.21037/arh.2017.04.03"]}, {"Citation": "Thakur GS, Bag M, Sanodiya BS, Bhadouriya P, Debnath M, Prasad GB, Bisen PS. Momordica balsamina: a medicinal and neutraceutical plant for health care management. Curr Pharm Biotechnol. 2009;10:667\u2013682. doi: 10.2174/138920109789542066.", "ArticleIdList": ["10.2174/138920109789542066", "19751180"]}, {"Citation": "Balzarini J. Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses? Antivir Chem Chemother. 2007;18:1\u201311. doi: 10.1177/095632020701800101.", "ArticleIdList": ["10.1177/095632020701800101", "17354647"]}, {"Citation": "Akkouh O, Ng TB, Singh SS, Yin C, Dan X, Chan YS, Pan W, Cheung RC. Lectins with anti-HIV activity: a review. Molecules. 2015;20:648\u2013668. doi: 10.3390/molecules20010648.", "ArticleIdList": ["10.3390/molecules20010648", "PMC6272367", "25569520"]}, {"Citation": "Mazalovska M, Kouokam JC. Lectins as promising therapeutics for the prevention and treatment of HIV and other potential coinfections. Biomed Res Int. 2018;2018:3750646. doi: 10.1155/2018/3750646.", "ArticleIdList": ["10.1155/2018/3750646", "PMC5964492", "29854749"]}, {"Citation": "Mitchell CA, Ramessar K, O\u2019Keefe BR. Antiviral lectins: selective inhibitors of viral entry. Antivir Res. 2017;142:37\u201354. doi: 10.1016/j.antiviral.2017.03.007.", "ArticleIdList": ["10.1016/j.antiviral.2017.03.007", "PMC5414728", "28322922"]}, {"Citation": "Ribeiro AC, Ferreira R, Freitas R. Chapter 1\u2014plant lectins: bioactivities and bioapplications. In: Atta ur Rahman, editor. Studies in natural products chemistry. Amsterdam: Elsevier; 2018. pp. 1\u201342."}, {"Citation": "Pusztai A, Grant G. Assessment of lectin inactivation by heat and digestion. Methods Mol Med. 1998;9:505\u2013514.", "ArticleIdList": ["21374488"]}, {"Citation": "Balzarini J, Van Laethem K, Hatse S, Froeyen M, Peumans W, Van Damme E, Schols D. Carbohydrate-binding agents cause deletions of highly conserved glycosylation sites in HIV GP120: a new therapeutic concept to hit the achilles heel of HIV. J Biol Chem. 2005;280:41005\u201341014. doi: 10.1074/jbc.M508801200.", "ArticleIdList": ["10.1074/jbc.M508801200", "16183648"]}, {"Citation": "Punja ZK, Zhang YY. Plant chitinases and their roles in resistance to fungal diseases. J Nematol. 1993;25:526\u2013540.", "ArticleIdList": ["PMC2619419", "19279806"]}, {"Citation": "Kesari P, Patil DN, Kumar P, Tomar S, Sharma AK, Kumar P. Structural and functional evolution of chitinase-like proteins from plants. Proteomics. 2015;15:1693\u20131705. doi: 10.1002/pmic.201400421.", "ArticleIdList": ["10.1002/pmic.201400421", "25728311"]}, {"Citation": "Terwisscha van Scheltinga AC, Kalk KH, Beintema JJ, Dijkstra BW. Crystal structures of hevamine, a plant defence protein with chitinase and lysozyme activity, and its complex with an inhibitor. Structure. 1994;2:1181\u20131189. doi: 10.1016/S0969-2126(94)00120-0.", "ArticleIdList": ["10.1016/S0969-2126(94)00120-0", "7704528"]}, {"Citation": "Coleman MI, Khan M, Gbodossou E, Diop A, DeBarros K, Duong H, Bond VC, Floyd V, Kondwani K, Montgomery Rice V, et al. Identification of a novel anti-HIV-1 protein from Momordica balsamina leaf extract. Int J Environ Res Public Health. 2022;19:15227. doi: 10.3390/ijerph192215227.", "ArticleIdList": ["10.3390/ijerph192215227", "PMC9690441", "36429944"]}, {"Citation": "Di Veroli GY, Fornari C, Goldlust I, Mills G, Koh SB, Bramhall JL, Richards FM, Jodrell DI. An automated fitting procedure and software for dose-response curves with multiphasic features. Sci Rep. 2015;5:14701. doi: 10.1038/srep14701.", "ArticleIdList": ["10.1038/srep14701", "PMC4589737", "26424192"]}, {"Citation": "He Y, Cheng J, Lu H, Li J, Hu J, Qi Z, Liu Z, Jiang S, Dai Q. Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strains. Proc Natl Acad Sci USA. 2008;105:16332\u201316337. doi: 10.1073/pnas.0807335105.", "ArticleIdList": ["10.1073/pnas.0807335105", "PMC2571013", "18852475"]}, {"Citation": "Lee-Huang S, Huang PL, Nara PL, Chen HC, Kung HF, Huang P, Huang HI, Huang PL. MAP 30: a new inhibitor of HIV-1 infection and replication. FEBS Lett. 1990;272:12\u201318. doi: 10.1016/0014-5793(90)80438-O.", "ArticleIdList": ["10.1016/0014-5793(90)80438-O", "1699801"]}, {"Citation": "Wierenga RK. The TIM-barrel fold: a versatile framework for efficient enzymes. FEBS Lett. 2001;492:193\u2013198. doi: 10.1016/S0014-5793(01)02236-0.", "ArticleIdList": ["10.1016/S0014-5793(01)02236-0", "11257493"]}, {"Citation": "Romero-Romero S, Costas M, Silva Manzano D-A, Kordes S, Rojas-Ortega E, Tapia C, Guerra Y, Shanmugaratnam S, Rodr\u00edguez-Romero A, Baker D, et al. The stability landscape of de novo TIM barrels explored by a modular design approach. J Mol Biol. 2021;433:167153\u2013167153. doi: 10.1016/j.jmb.2021.167153.", "ArticleIdList": ["10.1016/j.jmb.2021.167153", "PMC8404036", "34271011"]}, {"Citation": "Cao L, Diedrich JK, Kulp DW, Pauthner M, He L, Park S-KR, Sok D, Su CY, Delahunty CM, Menis S, et al. Global site-specific N-glycosylation analysis of HIV envelope glycoprotein. Nat Commun. 2017;8:14954. doi: 10.1038/ncomms14954.", "ArticleIdList": ["10.1038/ncomms14954", "PMC5379070", "28348411"]}, {"Citation": "Barre A, Bourne Y, Van Damme EJM, Roug\u00e9 P. Overview of the structure-function relationships of mannose-specific lectins from plants, algae and fungi. Int J Mol Sci. 2019;20:254. doi: 10.3390/ijms20020254.", "ArticleIdList": ["10.3390/ijms20020254", "PMC6359319", "30634645"]}, {"Citation": "Tesfaye M, Silverstein KA, Nallu S, Wang L, Botanga CJ, Gomez SK, Costa LM, Harrison MJ, Samac DA, Glazebrook J, et al. Spatio-temporal expression patterns of Arabidopsis thaliana and Medicago truncatula defensin-like genes. PLoS ONE. 2013;8:e58992. doi: 10.1371/journal.pone.0058992.", "ArticleIdList": ["10.1371/journal.pone.0058992", "PMC3601123", "23527067"]}, {"Citation": "Sahai AS, Manocha MS. Chitinases of fungi and plants: their involvement in morphogenesis and host\u2014parasite interaction. FEMS Microbiol Rev. 1993;11:317\u2013338. doi: 10.1111/j.1574-6976.1993.tb00004.x.", "ArticleIdList": ["10.1111/j.1574-6976.1993.tb00004.x"]}, {"Citation": "Henrissat B. A classification of glycosyl hydrolases based on amino acid sequence similarities. Biochem J. 1991;280(Pt 2):309\u2013316. doi: 10.1042/bj2800309.", "ArticleIdList": ["10.1042/bj2800309", "PMC1130547", "1747104"]}, {"Citation": "Samac DA, Hironaka CM, Yallaly PE, Shah DM. Isolation and characterization of the genes encoding basic and acidic chitinase in Arabidopsis thaliana. Plant Physiol. 1990;93:907\u2013914. doi: 10.1104/pp.93.3.907.", "ArticleIdList": ["10.1104/pp.93.3.907", "PMC1062608", "16667600"]}, {"Citation": "Bateman A, Bycroft M. The structure of a LysM domain from E. coli membrane-bound lytic murein transglycosylase D (MltD) J Mol Biol. 2000;299:1113\u20131119. doi: 10.1006/jmbi.2000.3778.", "ArticleIdList": ["10.1006/jmbi.2000.3778", "10843862"]}, {"Citation": "Percudani R, Montanini B, Ottonello S. The anti-HIV cyanovirin-N domain is evolutionarily conserved and occurs as a protein module in eukaryotes. Proteins. 2005;60:670\u2013678. doi: 10.1002/prot.20543.", "ArticleIdList": ["10.1002/prot.20543", "16003744"]}, {"Citation": "Boyd MR, Gustafson KR, McMahon JB, Shoemaker RH, O'Keefe BR, Mori T, Gulakowski RJ, Wu L, Rivera MI, Laurencot CM, et al. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development. Antimicrob Agents Chemother. 1997;41:1521\u20131530. doi: 10.1128/AAC.41.7.1521.", "ArticleIdList": ["10.1128/AAC.41.7.1521", "PMC163952", "9210678"]}, {"Citation": "Balzarini J. Inhibition of HIV entry by carbohydrate-binding proteins. Antivir Res. 2006;71:237\u2013247. doi: 10.1016/j.antiviral.2006.02.004.", "ArticleIdList": ["10.1016/j.antiviral.2006.02.004", "16569440"]}, {"Citation": "Khan M, Garcia-Barrio M, Powell MD. Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription. J Virol. 2001;75:12081\u201312087. doi: 10.1128/JVI.75.24.12081-12087.2001.", "ArticleIdList": ["10.1128/JVI.75.24.12081-12087.2001", "PMC116103", "11711598"]}, {"Citation": "Raymond AD, Campbell-Sims TC, Khan M, Lang M, Huang MB, Bond VC, Powell MD. HIV Type 1 Nef is released from infected cells in CD45(+) microvesicles and is present in the plasma of HIV-infected individuals. AIDS Res Hum Retrovir. 2011;27:167\u2013178. doi: 10.1089/aid.2009.0170.", "ArticleIdList": ["10.1089/aid.2009.0170", "PMC3064529", "20964480"]}, {"Citation": "Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015;10:845\u2013858. doi: 10.1038/nprot.2015.053.", "ArticleIdList": ["10.1038/nprot.2015.053", "PMC5298202", "25950237"]}, {"Citation": "Hood MA. Comparison of four methods for measuring chitinase activity and the application of the 4-MUF assay in aquatic environments. J Microbiol Methods. 1991;13:151\u2013160. doi: 10.1016/0167-7012(91)90015-I.", "ArticleIdList": ["10.1016/0167-7012(91)90015-I"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "12", "Day": "14"}, {"Year": "2023", "Month": "3", "Day": "13"}, {"Year": "2023", "Month": "3", "Day": "23", "Hour": "0", "Minute": "35"}, {"Year": "2023", "Month": "3", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["36949470", "PMC10035133", "10.1186/s12985-023-02010-5", "10.1186/s12985-023-02010-5"]}}], "PubmedBookArticle": []}